Skip to content
Study details
Enrolling now

RISE Trial

Dartmouth-Hitchcock Medical Center
NCT IDNCT05956158ClinicalTrials.gov data as of Apr 2026
Target enrollment

83

Study length

about 3 years

Ages

18+

Locations

1 site in NH

About this study

Researchers are testing whether a behavioral treatment and sleep education treatment can help people with Crohn's disease who have insomnia. The trial will last for 1098 days and involve approximately 83 participants.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Participate in Behavioral Treatment
  • 2.Participate in Sleep Education Treatment

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low7%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Secondary: Change in Crohn's disease symptoms as measured by the Patient Reported Outcomes 3, Change in insomnia symptoms as measured by the Insomnia Severity Index

Body systems

Gastroenterology